Evidence map›Paper›PMID 24903884›Full record

ArticleCurrent protocols in chemical biology2014

Manipulating natural product biosynthetic pathways via DNA assembler.

Zengyi Shao, Huimin Zhao

Abstract read
In one paragraph

Article in Current protocols in chemical biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Metabolic engineering of low-pH-tolerant non-model yeast,Metabolic engineering communications · 2023
    Article
  6. Review
  7. Increasing the heterologous production of spinosad inSynthetic and systems biotechnology · 2021
    Article
  8. 3 Biotech · 2021
    Review
  9. Metabolic engineering of an acid-tolerant yeast strainMetabolic engineering communications · 2020
    Article
  10. Synthetic Biology Approaches to EngineerLife (Basel, Switzerland) · 2020
    Review
  11. Article
  12. Article
  13. Review
  14. Heterologous expression-facilitated natural products' discovery in actinomycetes.Journal of industrial microbiology & biotechnology · 2019
    Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Zengyi ShaoDepartment of Chemical and Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois.
Huimin ZhaoDepartment of Chemical and Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois.
Iowa State University · USUniversity of Illinois Urbana-Champaign · US

Funding

Structural Elucidation and Biosynthesis P01GM077596 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI METCALF, WILLIAM W · 2007 to 2016
$15.3M
NIGMS NIH HHS GM077596NIGMS NIH HHS P01 GM077596
6 · The paper itself

Abstract

DNA assembler is an efficient synthetic biology method for constructing and manipulating biochemical pathways. The rapidly increasing number of sequenced genomes provides a rich source for discovery of gene clusters involved in synthesizing new natural products. However, both discovery and economical production are hampered by our limited knowledge in manipulating most organisms and the corresponding pathways. By taking advantage of yeast in vivo homologous recombination, DNA assembler synthesizes an entire expression vector containing the target biosynthetic pathway and the genetic elements needed for DNA maintenance and replication. Here we use the spectinabilin clusters originated from two hosts as examples to illustrate the guidelines of using DNA assembler for cluster characterization and silent cluster activation. Such strategies offer unprecedented versatility in cluster manipulation, bypass the traditional laborious strategies to elicit pathway expression, and provide a new platform for de novo cluster assembly and genome mining for discovering new natural products.

Indexed as

AntimalarialsAntiviral AgentsBiological ProductsBiosynthetic PathwaysCloning, MolecularDeoxyribonucleasesDNADNA PrimersGene DeletionMultigene FamilyPyronesStreptomycesStreptomyces lividansAntimalarialsAntiviral AgentsBiological ProductsDeoxyribonucleasesDNADNA PrimersPyronesspectinabilincryptic pathwayDNA assemblergene clusternatural productpathway engineeringregulation of natural product biosynthesissynthetic biology

Identifiers

PMID24903884
PMCPMC4105043
OpenAlexW1567454281

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.